CMMB

Chemomab Therapeutics

12 hedge funds and large institutions have $3.34M invested in Chemomab Therapeutics in 2023 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 0 increasing their positions, 3 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
12
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Buyers

1 +$3.94K

Top Sellers

1 -$458K
2 -$48.1K
3 -$30.5K
4
Two Sigma Advisers
Two Sigma Advisers
New York
-$18.8K
5
Morgan Stanley
Morgan Stanley
New York
-$10.2K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.95M
2
$280K
3
$41.1K
4
$34.9K
5
$15.4K
6
$14.7K
7
$3.94K
8
$3.58K
9
$1.45K
10
$132
11
$16
12
13
14